Recurrent Urothelial Carcinoma
4 clinical trials · Condition
◉ Watch Recurrent Urothelial Carcinoma
| Record | Firm | Date |
|---|---|---|
| Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy (NCT04963153) | National Cancer Institute (NCI) | 2022-07-07 |
| Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV (NCT04514484) | National Cancer Institute (NCI) | 2021-11-22 |
| ARID1A and/or KDM6A Mutation and CXCL13 Expression (NCT04953104) | M.D. Anderson Cancer Center | 2021-09-21 |
| Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction (NCT00365157) | National Cancer Institute (NCI) | 2006-10-23 |
Track Recurrent Urothelial Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.